DGHS chief: China may run coronavirus vaccine trial in Bangladesh
Jun 28 2020
RNA is ribonucleic acid, or genetic material and saRNA is being touted as a way to revolutionize vaccine development.
The first healthy volunteer has received a "small dose" of a potential Covid-19 vaccine developed by researchers from Imperial College London. Serum Institute of India invested 100 million Dollars to produce one million doses for India along with other developing countries.
The vaccine is being developed with more than £41 million worth of funding from the United Kingdom and a further £5 million in philanthropic donations. The participants in the Phase 2-3 trial will be randomised to receive either one or two doses of the candidate vaccine or a control vaccine (MenACWY) that protects against four strains of meningococcal bacteria. World Health Organization is drafting guidelines for the ethical distribution of COVID-19 vaccines.
"The aim of the vaccine is to trick the body into thinking it has already seen the virus and made an immune response, so when you come into contact with it in real life, you should already be immune".
The vaccine has become the first to enter the final stages of clinical trials to assess how well it works in protecting people from becoming infected by the virus that causes the coronavirus disease.
Britain's Prince William on Wednesday visited the Oxford-based scientists who are working to develop a viable vaccine for COVID-19 as well as trial participants who are helping to determine whether or not it works. "I look forward to our progress in the coming months". Hearteningly, we have both the skills and opportunity to harness South Africa's tech innovators right now to ensure that we are well-prepared for a vaccine - and have in place the best systems for its safe and efficient distribution.
"This vaccine has shown very good results in trials with chimpanzees and has already moved on to the next phase of human trials".
The UK Medical Research Council, UK Research and Innovation, the Department of Health and Social Care, the Department for Business, Energy and Industrial Strategy, the National Institute for Health Research, among others have supported the research effort. By June 17, South Africa contributed to 30% of all diagnosed Covid-19 cases and 23% of all Covid-19 deaths on the African continent.